Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy
International Journal of Urology · 2025
DOI: 10.1111/iju.70149 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Kojiro Tashiro und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Lymphatic Metastasis, Lymph Nodes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Post‐radical prostatectomy (RP) lymph node positivity (pN1) is associated with disease progression. However, the optimal treatment strategy for pN1 patients has remained unclear. This study aimed to establish a risk model for predicting survival outcomes in these patients.
Methods
We retrospectively studied 528 eligible patients with pN1 undergoing RP with pelvic lymph node dissection between 2006 and 2019 at 33 participant institutions in the Japanese Urologic Oncology Study Group. Metastasis‐free survival (MFS) was used to evaluate for survival outcome. A least absolute shrinkage and selection operator (LASSO)‐penalized, multivariate Cox regression model for MFS was used to evaluate patients for their risk factors and establish a risk model with an associated nomogram.
Results
Grade group (GGs 4–5 vs. GGs 1–3: HR, 7.35; 95% confidence intervals (CI), 1.76–30.7; p = 0.006), pathological T‐stage (pT3b or more vs. pT2 to pT3a: HR, 2.01; 95% CI, 0.93–4.34; p = 0.075), number of positive lymph nodes (HR, 2.03; 95% CI, 0.83–4.96; p = 0.044), and positive lymph node diameter (> 2 mm vs. ≤ 2 mm: HR, 2.03; 95% CI, 1.09–9.00; p = 0.034) were identified as independent prognostic factors for predicting 60‐month MFS.
Conclusions
This study explored prognostic factors for pN1 prostate cancer patients for predicting their MFS and identified a risk model involving a nomogram. Randomized controlled trials are necessary in patients with pN1 prostate cancer to elucidate optimal postoperative treatment indications and selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Urology, Kyushu University, Fukuoka, Japan.
- Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Urology, Nagoya University, Aichi, Japan.
- Department of Urology and Andrology, Kansai Medical University, Osaka, Japan.
- Department of Urology, Harasanshin Hospital, Japan Division of Urology, Fukuoka, Japan.
ORCID-Profile: Kojiro Tashiro, Keiichiro Mori, Masaki Shiota, Wataru Fukuokaya, Masashi Kato, Ryoichi Saito, Akira Yokomizo, Makito Miyake, Hiroshi Kitamura, Takahiro Kimura
Zitieren
APA
Tashiro, K., Mori, K., Shiota, M., Fukuokaya, W., Takamatsu, D., Matsui, Y., Kato, M., Saito, R., Yokomizo, A., Tsutsumi, M., Yamamoto, Y., Edamura, K., Miyake, M., Morizane, S., Yoshino, T., Matsumoto, R., Narita, S., Kitamura, H., Eto, M., …, & Japanese Urological Oncology Group (2025). Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy. International Journal of Urology. https://doi.org/10.1111/iju.70149
Vancouver
Tashiro K, Mori K, Shiota M, Fukuokaya W, Takamatsu D, Matsui Y, et al. Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy. International Journal of Urology. 2025. doi:10.1111/iju.70149
BibTeX
@article{Tashiro2025,
author = {Tashiro, Kojiro and Mori, Keiichiro and Shiota, Masaki and Fukuokaya, Wataru and Takamatsu, Dai and Matsui, Yoshiyuki and Kato, Masashi and Saito, Ryoichi and Yokomizo, Akira and Tsutsumi, Masakazu and Yamamoto, Yoshiyuki and Edamura, Kohei and Miyake, Makito and Morizane, Shuichi and Yoshino, Takayuki and Matsumoto, Ryuji and Narita, Shintaro and Kitamura, Hiroshi and Eto, Masatoshi and Kimura, Takahiro and Japanese Urological Oncology Group, Japanese Urological Oncology Group},
title = {Risk Model for Lymph Node‐Positive Prostate Cancer After Radical Prostatectomy},
journal = {International Journal of Urology},
year = {2025},
doi = {10.1111/iju.70149}
}
EUVIMED